Unknown

Dataset Information

0

Factors related to the improvement in quality of life for depressed inpatients treated with fluoxetine.


ABSTRACT: BACKGROUND:The aim of this study was to explore the relationships between depressive symptoms and health-related quality of life (HRQOL) measurements for inpatients with major depressive disorder (MDD) before and after 6-week fluoxetine treatment, and to elucidate the factors related to the HRQOL changes. METHODS:A total of 131 inpatients with MDD were enrolled to receive 20 mg of fluoxetine for 6 weeks. Symptom severity and adverse events were assessed at weeks 0, 1, 2, 3, 4, and 6 using the 17-item Hamilton Depression Rating Scale (HAMD-17) and UKU Side Effect Rating Scale, respectively. HRQOL was measured using the Short Form 36 (SF-36), including 8 subscales, physical component summary (PCS) and mental component summary (MCS), at baseline and week 6. Spearman's coefficient, Cohen's d, and multiple linear regression model were used for statistical analysis. RESULTS:One hundred and six patients completing all measures at weeks 0 and 6 entered the analysis. HAMD-17 negatively correlated with SF-36 at baseline and week 6. The HAMD-17 had a larger effect size than SF-36. MCS, rather than PCS, showed statistically significant improvement. After using multiple linear regression analysis, age at onset, HAMD-17 score change, and number of adverse events reported during the trial period were related to MCS change after adjusting for confounding variables. CONCLUSIONS:Fluoxetine treatment was associated with an improvement in depressive symptomology and HRQOL. Depressive symptoms had a greater extent of change than HRQOL. Clinicians must consider the negative effects of adverse events caused by antidepressants on the improvement of HRQOL. TRIAL REGISTRATION:http://clinicaltrials.gov , NCT01075529 , retrospectively registered 24/2/2010.

SUBMITTER: Yang WC 

PROVIDER: S-EPMC5574134 | biostudies-literature | 2017 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Factors related to the improvement in quality of life for depressed inpatients treated with fluoxetine.

Yang Wei-Cheng WC   Lin Ching-Hua CH   Wang Fu-Chiang FC   Lu Mei-Jou MJ  

BMC psychiatry 20170825 1


<h4>Background</h4>The aim of this study was to explore the relationships between depressive symptoms and health-related quality of life (HRQOL) measurements for inpatients with major depressive disorder (MDD) before and after 6-week fluoxetine treatment, and to elucidate the factors related to the HRQOL changes.<h4>Methods</h4>A total of 131 inpatients with MDD were enrolled to receive 20 mg of fluoxetine for 6 weeks. Symptom severity and adverse events were assessed at weeks 0, 1, 2, 3, 4, and  ...[more]

Similar Datasets

| S-EPMC7330870 | biostudies-literature
| S-EPMC5506697 | biostudies-literature
| S-EPMC6312587 | biostudies-literature
| S-EPMC5876847 | biostudies-other
| S-EPMC7847550 | biostudies-literature
| S-EPMC6676643 | biostudies-literature
| S-EPMC4254122 | biostudies-literature
| S-EPMC8012720 | biostudies-literature
| S-EPMC5922485 | biostudies-literature
| S-EPMC3606673 | biostudies-literature